Skip to content
healthcare.dev
Get a free key

ABRAXANE

NDC 68817-134, Paclitaxel, injection, powder, lyophilized, for suspension, from Abraxis BioScience, LLC.

Product NDC
68817-134
Status
Listed
Labeler
Abraxis BioScience, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021660
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68817-134 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PACLITAXEL100 mg/20mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
68817-134-50688170134501 VIAL, SINGLE-USE in 1 CARTON (68817-134-50) / 20 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/24d10449-2936-4cd3-b7db-a7683db721e4

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68817-134

Use it

Look up 68817-134 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68817-134 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68817-134. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.